Use of polyamine antimetabolites in experimental tumours and in human leukemia.
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D000518:Eflornithine; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008935:Mitoguazone / Q000494:pharmacology / Q000627:therapeutic use; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009952:Ornithine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D011073:Polyamines / Q000096:biosynthesis*
D000964:Antimetabolites, Antineoplastic; D011073:Polyamines; D009952:Ornithine; D008935:Mitoguazone; D000518:Eflornithine